{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:49:21Z","timestamp":1780098561476,"version":"3.54.0"},"reference-count":144,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>Yellow fever (YF) causes approximately 50,000 deaths annually worldwide and is transmitted by infection with the yellow fever virus (YFV), which is endemic in Sub-Saharan Africa and tropical South America. The live-attenuated YFV 17D vaccine, developed in 1937, is essential to control YFV transmission, but the finite shelf life and manufacturing constraints of egg-based vaccine production, the rare but severe adverse events, and the lack of effective therapeutic options for YF disease highlight the need for new YFV vaccines and therapies. Potent YFV antibodies that neutralize circulating strains could be promising passive immunizations or treatments and guide nonreplicating YF vaccine development. In this study, we captured and screened natively paired heavy and light chain antibody libraries from two donors immunized with the YFV 17D vaccine. Yeast surface display libraries were generated and stained using YF virus-like particles purified by chromatographic techniques. Three anti-YFV antibodies were identified with potent neutralizing activity against circulating strains from Western Africa and South America, including one potent antibody with a neutralizing half-maximal inhibitory concentration of &lt;5 ng\/mL against the 17D vaccine strain. These new YFV antibodies have the potential to serve as YFV outbreak countermeasures for treatment or prevention and guide future vaccine efforts.<\/jats:p>","DOI":"10.4269\/ajtmh.25-0057","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:14:57Z","timestamp":1763658897000},"page":"174-184","source":"Crossref","is-referenced-by-count":1,"title":["Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D Vaccine"],"prefix":"10.4269","volume":"114","author":[{"given":"Matheus O.","family":"de Souza","sequence":"first","affiliation":[{"name":"The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts;"},{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts;"},{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle R. D.","family":"Saunders","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas;"},{"name":"Biosecurity Research Institute, Kansas State University, Manhattan, Kansas;"},{"name":"Department of Biology, United States Air Force Academy, Colorado Springs, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Purdue University, West Lafayette, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Fahad","sequence":"additional","affiliation":[{"name":"The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts;"},{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts;"},{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan R.","family":"Timm","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Petrova","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Dowd","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Madan","sequence":"additional","affiliation":[{"name":"The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts;"},{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts;"},{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacy","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Normandin","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Henry","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Laboune","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Misasi","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00falio M.","family":"Lima","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata G. F.","family":"Alvim","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egan M.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Burgomaster","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[{"name":"The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts;"},{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts;"},{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Vanlandingham","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas;"},{"name":"Biosecurity Research Institute, Kansas State University, Manhattan, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Higgs","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas;"},{"name":"Biosecurity Research Institute, Kansas State University, Manhattan, Kansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Douek","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Coates","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"},{"name":"ModeX Therapeutics, Weston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda R.","family":"Castilho","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Purdue University, West Lafayette, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jang S.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas;"},{"name":"Department of Microbiology and Immunology and, State University of New York Center for Vector-Borne Diseases, Upstate Medical University, Syracuse, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"DeKosky","sequence":"additional","affiliation":[{"name":"The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts;"},{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts;"},{"name":"Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas;"},{"name":"Department of Chemical Engineering, The University of Kansas, Lawrence, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Vaccines (Basel)","first-page":"372","article-title":"Yellow fever: Origin, epidemiology, preventive strategies and future prospects","volume":"10","author":"Gianchecchi","year":"2022"},{"key":"b2","series-title":"Trends Microbiol","first-page":"913","article-title":"Yellow fever virus: Knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018"},{"key":"b3","series-title":"Antiviral Res","first-page":"104939","article-title":"Generation of a reporter yellow fever virus for high throughput antiviral assays","volume":"183","author":"Sanchez-Velazquez","year":"2020"},{"key":"b4","series-title":"N Engl J Med","first-page":"1397","article-title":"Yellow fever\u2014Once again on the radar screen in the Americas","volume":"376","author":"Paules","year":"2017"},{"key":"b5","series-title":"J Med Entomol","first-page":"1891","article-title":"Occurrence of the Sylvatic yellow fever vector mosquito Haemagogus leucocelaenus (Diptera: Culicidae) in an Atlantic forest fragment of the touristic State of Rio de Janeiro, Brazil","volume":"59","author":"Silva","year":"2022"},{"key":"b6","series-title":"Hum Vaccin Immunother","first-page":"1895644","article-title":"Re-thinking yellow fever vaccines: Fighting old foes with new generation vaccines","volume":"18","author":"Montalvo Zurbia-Flores","year":"2022"},{"key":"b7","series-title":"eLife","first-page":"e64670","article-title":"The global burden of yellow fever","volume":"10","author":"Gaythorpe","year":"2021"},{"key":"b8","series-title":"Science","first-page":"894","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361:","author":"Faria","year":"2018"},{"key":"b9","series-title":"Science","first-page":"847","article-title":"The reemergence of yellow fever","volume":"361","author":"Barrett","year":"2018"},{"key":"b10","series-title":"Virol J","first-page":"9","article-title":"Recent sylvatic yellow fever virus transmission in Brazil: The news from an old disease","volume":"17","author":"Silva","year":"2020"},{"key":"b11","series-title":"Viruses","first-page":"1233","article-title":"Re-emergence of yellow fever in Brazil during 2016\u20132019: Challenges, lessons learned, and perspectives","volume":"12","author":"de Oliveira Figueiredo","year":"2020"},{"key":"b12","article-title":"Disease Outbreak News.","year":"2024"},{"key":"b13","series-title":"J Venom Anim Toxins Incl Trop Dis","first-page":"20","article-title":"Yellow fever in Africa and the Americas: A historical and epidemiological perspective","volume":"24","author":"Chippaux","year":"2018"},{"key":"b14","article-title":"Yellow fever in African Region (AFRO).","year":"2024"},{"key":"b15","series-title":"Nat Rev Microbiol","first-page":"13","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005"},{"key":"b16","series-title":"mBio","first-page":"e01871-18","article-title":"Structural and nonstructural genes contribute to the genetic diversity of RNA viruses","volume":"9","author":"Collins","year":"2018"},{"key":"b17","series-title":"Microbes Infect","first-page":"1","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011"},{"key":"b18","series-title":"Curr Opin Virol","first-page":"51","article-title":"Mapping the diverse structural landscape of the flavivirus antibody repertoire","volume":"45","author":"Sevvana","year":"2020"},{"key":"b19","series-title":"Curr Infect Dis Rep","first-page":"14","article-title":"Live attenuated yellow fever 17D vaccine: A legacy vaccine still controlling outbreaks in modern day","volume":"19","author":"Collins","year":"2017"},{"key":"b20","series-title":"PLoS One","first-page":"e0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016"},{"key":"b21","series-title":"PLoS One","first-page":"e49828","article-title":"17DD and 17D-213\/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children","volume":"7","author":"Campi-Azevedo","year":"2012"},{"key":"b22","series-title":"Virology","first-page":"160","article-title":"Heterogeneity in envelope protein sequence and N-Linked glycosylation among yellow fever virus vaccine strains","volume":"188","author":"Post","year":"1992"},{"key":"b23","series-title":"Expert Rev Vaccines","first-page":"1479","article-title":"Current status and future prospects of yellow fever vaccines","volume":"14","author":"Beck","year":"2015"},{"key":"b24","series-title":"Am J Trop Med Hyg","first-page":"359","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: Systematic review","volume":"86","author":"Williamson","year":"2012"},{"key":"b25","series-title":"Vaccine","first-page":"1727","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases","volume":"25","author":"McMahon","year":"2007"},{"key":"b26","series-title":"Pediatr Clin North Am","first-page":"427","article-title":"Current understanding of egg allergy","volume":"58","author":"Caubet","year":"2011"},{"key":"b27","series-title":"Pediatr Infect Dis J","first-page":"e76","article-title":"Yellow fever vaccination in egg-allergic children","volume":"39","author":"Sharma","year":"2020"},{"key":"b28","series-title":"Clin Exp Allergy","first-page":"1262","article-title":"BSACI 2021 guideline for the management of egg allergy","volume":"51","author":"Leech","year":"2021"},{"key":"b29","series-title":"Lancet Infect Dis","first-page":"1209","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: An adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017"},{"key":"b30","series-title":"Viruses","first-page":"1226","article-title":"Mosquito-borne flaviviruses and current therapeutic advances","volume":"14","author":"Qian","year":"2022"},{"key":"b31","series-title":"BioMed Res Int","first-page":"838491","article-title":"Possible future monoclonal antibody (mAb)-based therapy against Arbovirus infections","volume":"2013","author":"Sautto","year":"2013"},{"key":"b32","series-title":"IJMS","first-page":"54","article-title":"Development of antibody therapeutics against Flaviviruses","volume":"19","author":"Sun","year":"2017"},{"key":"b33","series-title":"Cell Rep","first-page":"438","article-title":"Double lock of a human neutralizing and protective monoclonal antibody targeting the yellow fever virus envelope","volume":"26","author":"Lu","year":"2019"},{"key":"b34","series-title":"Proc Natl Acad Sci USA","first-page":"6675","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020"},{"key":"b35","series-title":"mBio","first-page":"e00512-22","article-title":"Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus","volume":"13","author":"Doyle","year":"2022"},{"key":"b36","series-title":"Innovation (Camb)","first-page":"100323","article-title":"A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus","volume":"3","author":"Li","year":"2022"},{"key":"b37","series-title":"Sci Transl Med","first-page":"eade5795","article-title":"Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection","volume":"15","author":"Ricciardi","year":"2023"},{"key":"b38","series-title":"N Engl J Med","first-page":"452","article-title":"Phase 1 trial of a therapeutic anti-yellow fever virus human antibody","volume":"383","author":"Low","year":"2020"},{"key":"b39","series-title":"Nat Med","first-page":"1331","article-title":"Monoclonal antibodies for yellow fever","volume":"26","author":"Stower","year":"2020"},{"key":"b40","series-title":"Nat Med","first-page":"86","article-title":"In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire","volume":"21","author":"DeKosky","year":"2015"},{"key":"b41","series-title":"Nat Biotechnol","first-page":"152","article-title":"Functional interrogation and mining of natively paired human VH: VL antibody repertoires","volume":"36","author":"Wang","year":"2018"},{"key":"b42","series-title":"J Biosci Bioeng","first-page":"226","article-title":"Ultrasonically-guided flow focusing generates precise emulsion droplets for high-throughput single cell analyses","volume":"128","author":"Lagerman","year":"2019"},{"key":"b43","series-title":"Nat Protoc","first-page":"429","article-title":"Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes","volume":"11","author":"McDaniel","year":"2016"},{"key":"b44","series-title":"Nat Biotechnol","first-page":"166","article-title":"High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire","volume":"31","author":"DeKosky","year":"2013"},{"key":"b45","series-title":"Biotechnol Bioeng","first-page":"3581","article-title":"Process intensification for the production of yellow fever virus\u2010like particles as potential recombinant vaccine antigen","volume":"118","author":"Alvim","year":"2021"},{"key":"b46","series-title":"Vaccine","first-page":"7061","article-title":"Purification of flavivirus VLPs by a two-step chomatographic process","volume":"37","author":"Lima","year":"2019"},{"key":"b47","series-title":"Front Immunol","first-page":"615102","article-title":"Functional profiling of antibody immune repertoires in convalescent zika virus disease patients","volume":"12","author":"Fahad","year":"2021"},{"key":"b48","series-title":"Cell Rep","first-page":"109771","article-title":"Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses","volume":"37","author":"Banach","year":"2021"},{"key":"b49","series-title":"AIChE J","first-page":"e17440","article-title":"Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS\u2010CoV \u20102","volume":"67","author":"Madan","year":"2021"},{"key":"b50","series-title":"Front Immunol","first-page":"977064","article-title":"Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens","volume":"13","author":"de Souza","year":"2022"},{"key":"b51","series-title":"Antibodies","first-page":"39","article-title":"Strategies to screen anti-AQP4 antibodies from yeast surface display libraries","volume":"11","author":"Huang","year":"2022"},{"key":"b52","series-title":"Protein Complex Assembly","first-page":"101","author":"Medina-Cucurella","year":"2018"},{"key":"b53","series-title":"Nat Biotechnol","first-page":"543","article-title":"Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing","volume":"30","author":"Whitehead","year":"2012"},{"key":"b54","series-title":"Proc Natl Acad Sci USA","first-page":"e2011653118","article-title":"Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody","volume":"118","author":"Madan","year":"2021"},{"key":"b55","series-title":"J Infect Dis","first-page":"1550","article-title":"Limited flavivirus cross-reactive antibody responses elicited by a zika virus deoxyribonucleic acid vaccine candidate in humans","volume":"224","author":"Burgomaster","year":"2021"},{"key":"b56","series-title":"Cell","first-page":"717","article-title":"Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002"},{"key":"b57","series-title":"mBio","first-page":"e00824-22","article-title":"Monoclonal antibodies and flaviviruses: A possible option?","volume":"13","author":"Mancini","year":"2022"},{"key":"b58","series-title":"Ann Med Surg (Lond)","first-page":"104537","article-title":"Yellow fever outbreak in Kenya: A review","volume":"82","author":"Uwishema","year":"2022"},{"key":"b59","series-title":"PLoS Negl Trop Dis","first-page":"e0010741","article-title":"Occurrence of yellow fever outbreaks in a partially vaccinated population: An analysis of the effective reproduction number","volume":"16","author":"Ferreira Fc da","year":"2022"},{"key":"b60","series-title":"Npj Vaccines","first-page":"137","article-title":"Yellow fever resurgence: An avoidable crisis?","volume":"7","author":"Lindsey","year":"2022"},{"key":"b61","series-title":"Virology","first-page":"262","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"Daffis","year":"2005"},{"key":"b62","series-title":"Cell Host Microbe","first-page":"229","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development","volume":"4","author":"Pierson","year":"2008"},{"key":"b63","series-title":"Viruses","first-page":"338","article-title":"Structures and functions of the envelope glycoprotein in flavivirus infections","volume":"9","author":"Zhang","year":"2017"},{"key":"b64","series-title":"Elife","first-page":"e82447","article-title":"A pH-dependent cluster of charges in a conserved cryptic pocket on flaviviral envelopes","volume":"12","author":"Zuzic","year":"2023"},{"key":"b65","series-title":"mBio","first-page":"e02294-19","article-title":"Attenuation of live-attenuated yellow fever 17D vaccine virus is localized to a high-fidelity replication complex","volume":"10","author":"Davis","year":"2019"},{"key":"b66","series-title":"Viruses","first-page":"527","article-title":"Genetic diversity does not contribute to attenuation of HeLa passaged wild-type yellow fever virus strain French viscerotropic virus","volume":"14","author":"Strother","year":"2022"},{"key":"b67","series-title":"Science","first-page":"467","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016"},{"key":"b68","series-title":"Nat Struct Mol Biol","first-page":"105","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013"},{"key":"b69","series-title":"J Virol","first-page":"2337","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012"},{"key":"b70","series-title":"Proc Natl Acad Sci USA","first-page":"12400","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006"},{"key":"b71","series-title":"Viruses","first-page":"1346","article-title":"Structural basis of zika virus specific neutralization in subsequent flavivirus infections","volume":"12","author":"Sevvana","year":"2020"},{"key":"b72","series-title":"Cell","first-page":"6067","article-title":"Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics","volume":"184","author":"Lim","year":"2021"},{"key":"b1","series-title":"Vaccines (Basel)","first-page":"372","article-title":"Yellow fever: Origin, epidemiology, preventive strategies and future prospects","volume":"10","author":"Gianchecchi","year":"2022"},{"key":"b2","series-title":"Trends Microbiol","first-page":"913","article-title":"Yellow fever virus: Knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018"},{"key":"b3","series-title":"Antiviral Res","first-page":"104939","article-title":"Generation of a reporter yellow fever virus for high throughput antiviral assays","volume":"183","author":"Sanchez-Velazquez","year":"2020"},{"key":"b4","series-title":"N Engl J Med","first-page":"1397","article-title":"Yellow fever\u2014Once again on the radar screen in the Americas","volume":"376","author":"Paules","year":"2017"},{"key":"b5","series-title":"J Med Entomol","first-page":"1891","article-title":"Occurrence of the Sylvatic yellow fever vector mosquito Haemagogus leucocelaenus (Diptera: Culicidae) in an Atlantic forest fragment of the touristic State of Rio de Janeiro, Brazil","volume":"59","author":"Silva","year":"2022"},{"key":"b6","series-title":"Hum Vaccin Immunother","first-page":"1895644","article-title":"Re-thinking yellow fever vaccines: Fighting old foes with new generation vaccines","volume":"18","author":"Montalvo Zurbia-Flores","year":"2022"},{"key":"b7","series-title":"eLife","first-page":"e64670","article-title":"The global burden of yellow fever","volume":"10","author":"Gaythorpe","year":"2021"},{"key":"b8","series-title":"Science","first-page":"894","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361:","author":"Faria","year":"2018"},{"key":"b9","series-title":"Science","first-page":"847","article-title":"The reemergence of yellow fever","volume":"361","author":"Barrett","year":"2018"},{"key":"b10","series-title":"Virol J","first-page":"9","article-title":"Recent sylvatic yellow fever virus transmission in Brazil: The news from an old disease","volume":"17","author":"Silva","year":"2020"},{"key":"b11","series-title":"Viruses","first-page":"1233","article-title":"Re-emergence of yellow fever in Brazil during 2016\u20132019: Challenges, lessons learned, and perspectives","volume":"12","author":"de Oliveira Figueiredo","year":"2020"},{"key":"b12","article-title":"Disease Outbreak News.","year":"2024"},{"key":"b13","series-title":"J Venom Anim Toxins Incl Trop Dis","first-page":"20","article-title":"Yellow fever in Africa and the Americas: A historical and epidemiological perspective","volume":"24","author":"Chippaux","year":"2018"},{"key":"b14","article-title":"Yellow fever in African Region (AFRO).","year":"2024"},{"key":"b15","series-title":"Nat Rev Microbiol","first-page":"13","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005"},{"key":"b16","series-title":"mBio","first-page":"e01871-18","article-title":"Structural and nonstructural genes contribute to the genetic diversity of RNA viruses","volume":"9","author":"Collins","year":"2018"},{"key":"b17","series-title":"Microbes Infect","first-page":"1","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011"},{"key":"b18","series-title":"Curr Opin Virol","first-page":"51","article-title":"Mapping the diverse structural landscape of the flavivirus antibody repertoire","volume":"45","author":"Sevvana","year":"2020"},{"key":"b19","series-title":"Curr Infect Dis Rep","first-page":"14","article-title":"Live attenuated yellow fever 17D vaccine: A legacy vaccine still controlling outbreaks in modern day","volume":"19","author":"Collins","year":"2017"},{"key":"b20","series-title":"PLoS One","first-page":"e0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016"},{"key":"b21","series-title":"PLoS One","first-page":"e49828","article-title":"17DD and 17D-213\/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children","volume":"7","author":"Campi-Azevedo","year":"2012"},{"key":"b22","series-title":"Virology","first-page":"160","article-title":"Heterogeneity in envelope protein sequence and N-Linked glycosylation among yellow fever virus vaccine strains","volume":"188","author":"Post","year":"1992"},{"key":"b23","series-title":"Expert Rev Vaccines","first-page":"1479","article-title":"Current status and future prospects of yellow fever vaccines","volume":"14","author":"Beck","year":"2015"},{"key":"b24","series-title":"Am J Trop Med Hyg","first-page":"359","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: Systematic review","volume":"86","author":"Williamson","year":"2012"},{"key":"b25","series-title":"Vaccine","first-page":"1727","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases","volume":"25","author":"McMahon","year":"2007"},{"key":"b26","series-title":"Pediatr Clin North Am","first-page":"427","article-title":"Current understanding of egg allergy","volume":"58","author":"Caubet","year":"2011"},{"key":"b27","series-title":"Pediatr Infect Dis J","first-page":"e76","article-title":"Yellow fever vaccination in egg-allergic children","volume":"39","author":"Sharma","year":"2020"},{"key":"b28","series-title":"Clin Exp Allergy","first-page":"1262","article-title":"BSACI 2021 guideline for the management of egg allergy","volume":"51","author":"Leech","year":"2021"},{"key":"b29","series-title":"Lancet Infect Dis","first-page":"1209","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: An adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017"},{"key":"b30","series-title":"Viruses","first-page":"1226","article-title":"Mosquito-borne flaviviruses and current therapeutic advances","volume":"14","author":"Qian","year":"2022"},{"key":"b31","series-title":"BioMed Res Int","first-page":"838491","article-title":"Possible future monoclonal antibody (mAb)-based therapy against Arbovirus infections","volume":"2013","author":"Sautto","year":"2013"},{"key":"b32","series-title":"IJMS","first-page":"54","article-title":"Development of antibody therapeutics against Flaviviruses","volume":"19","author":"Sun","year":"2017"},{"key":"b33","series-title":"Cell Rep","first-page":"438","article-title":"Double lock of a human neutralizing and protective monoclonal antibody targeting the yellow fever virus envelope","volume":"26","author":"Lu","year":"2019"},{"key":"b34","series-title":"Proc Natl Acad Sci USA","first-page":"6675","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020"},{"key":"b35","series-title":"mBio","first-page":"e00512-22","article-title":"Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus","volume":"13","author":"Doyle","year":"2022"},{"key":"b36","series-title":"Innovation (Camb)","first-page":"100323","article-title":"A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus","volume":"3","author":"Li","year":"2022"},{"key":"b37","series-title":"Sci Transl Med","first-page":"eade5795","article-title":"Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection","volume":"15","author":"Ricciardi","year":"2023"},{"key":"b38","series-title":"N Engl J Med","first-page":"452","article-title":"Phase 1 trial of a therapeutic anti-yellow fever virus human antibody","volume":"383","author":"Low","year":"2020"},{"key":"b39","series-title":"Nat Med","first-page":"1331","article-title":"Monoclonal antibodies for yellow fever","volume":"26","author":"Stower","year":"2020"},{"key":"b40","series-title":"Nat Med","first-page":"86","article-title":"In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire","volume":"21","author":"DeKosky","year":"2015"},{"key":"b41","series-title":"Nat Biotechnol","first-page":"152","article-title":"Functional interrogation and mining of natively paired human VH: VL antibody repertoires","volume":"36","author":"Wang","year":"2018"},{"key":"b42","series-title":"J Biosci Bioeng","first-page":"226","article-title":"Ultrasonically-guided flow focusing generates precise emulsion droplets for high-throughput single cell analyses","volume":"128","author":"Lagerman","year":"2019"},{"key":"b43","series-title":"Nat Protoc","first-page":"429","article-title":"Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes","volume":"11","author":"McDaniel","year":"2016"},{"key":"b44","series-title":"Nat Biotechnol","first-page":"166","article-title":"High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire","volume":"31","author":"DeKosky","year":"2013"},{"key":"b45","series-title":"Biotechnol Bioeng","first-page":"3581","article-title":"Process intensification for the production of yellow fever virus\u2010like particles as potential recombinant vaccine antigen","volume":"118","author":"Alvim","year":"2021"},{"key":"b46","series-title":"Vaccine","first-page":"7061","article-title":"Purification of flavivirus VLPs by a two-step chomatographic process","volume":"37","author":"Lima","year":"2019"},{"key":"b47","series-title":"Front Immunol","first-page":"615102","article-title":"Functional profiling of antibody immune repertoires in convalescent zika virus disease patients","volume":"12","author":"Fahad","year":"2021"},{"key":"b48","series-title":"Cell Rep","first-page":"109771","article-title":"Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses","volume":"37","author":"Banach","year":"2021"},{"key":"b49","series-title":"AIChE J","first-page":"e17440","article-title":"Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS\u2010CoV \u20102","volume":"67","author":"Madan","year":"2021"},{"key":"b50","series-title":"Front Immunol","first-page":"977064","article-title":"Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens","volume":"13","author":"de Souza","year":"2022"},{"key":"b51","series-title":"Antibodies","first-page":"39","article-title":"Strategies to screen anti-AQP4 antibodies from yeast surface display libraries","volume":"11","author":"Huang","year":"2022"},{"key":"b52","series-title":"Protein Complex Assembly","first-page":"101","author":"Medina-Cucurella","year":"2018"},{"key":"b53","series-title":"Nat Biotechnol","first-page":"543","article-title":"Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing","volume":"30","author":"Whitehead","year":"2012"},{"key":"b54","series-title":"Proc Natl Acad Sci USA","first-page":"e2011653118","article-title":"Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody","volume":"118","author":"Madan","year":"2021"},{"key":"b55","series-title":"J Infect Dis","first-page":"1550","article-title":"Limited flavivirus cross-reactive antibody responses elicited by a zika virus deoxyribonucleic acid vaccine candidate in humans","volume":"224","author":"Burgomaster","year":"2021"},{"key":"b56","series-title":"Cell","first-page":"717","article-title":"Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002"},{"key":"b57","series-title":"mBio","first-page":"e00824-22","article-title":"Monoclonal antibodies and flaviviruses: A possible option?","volume":"13","author":"Mancini","year":"2022"},{"key":"b58","series-title":"Ann Med Surg (Lond)","first-page":"104537","article-title":"Yellow fever outbreak in Kenya: A review","volume":"82","author":"Uwishema","year":"2022"},{"key":"b59","series-title":"PLoS Negl Trop Dis","first-page":"e0010741","article-title":"Occurrence of yellow fever outbreaks in a partially vaccinated population: An analysis of the effective reproduction number","volume":"16","author":"Ferreira Fc da","year":"2022"},{"key":"b60","series-title":"Npj Vaccines","first-page":"137","article-title":"Yellow fever resurgence: An avoidable crisis?","volume":"7","author":"Lindsey","year":"2022"},{"key":"b61","series-title":"Virology","first-page":"262","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"Daffis","year":"2005"},{"key":"b62","series-title":"Cell Host Microbe","first-page":"229","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development","volume":"4","author":"Pierson","year":"2008"},{"key":"b63","series-title":"Viruses","first-page":"338","article-title":"Structures and functions of the envelope glycoprotein in flavivirus infections","volume":"9","author":"Zhang","year":"2017"},{"key":"b64","series-title":"Elife","first-page":"e82447","article-title":"A pH-dependent cluster of charges in a conserved cryptic pocket on flaviviral envelopes","volume":"12","author":"Zuzic","year":"2023"},{"key":"b65","series-title":"mBio","first-page":"e02294-19","article-title":"Attenuation of live-attenuated yellow fever 17D vaccine virus is localized to a high-fidelity replication complex","volume":"10","author":"Davis","year":"2019"},{"key":"b66","series-title":"Viruses","first-page":"527","article-title":"Genetic diversity does not contribute to attenuation of HeLa passaged wild-type yellow fever virus strain French viscerotropic virus","volume":"14","author":"Strother","year":"2022"},{"key":"b67","series-title":"Science","first-page":"467","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016"},{"key":"b68","series-title":"Nat Struct Mol Biol","first-page":"105","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013"},{"key":"b69","series-title":"J Virol","first-page":"2337","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012"},{"key":"b70","series-title":"Proc Natl Acad Sci USA","first-page":"12400","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006"},{"key":"b71","series-title":"Viruses","first-page":"1346","article-title":"Structural basis of zika virus specific neutralization in subsequent flavivirus infections","volume":"12","author":"Sevvana","year":"2020"},{"key":"b72","series-title":"Cell","first-page":"6067","article-title":"Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics","volume":"184","author":"Lim","year":"2021"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/114\/1\/article-p174.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/114\/1\/article-p174.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/114\/1\/article-p174.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:52:53Z","timestamp":1767793973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/114\/1\/article-p174.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":144,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.25-0057","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}